Lunit selected as contractor for building medical AI platform in Singapore

South Korean medical AI company Lunit announced on Friday that it has been selected as the final contractor in the bidding for the establishment of the medical AI platform "AimSG" by SYNAPSE, Singapore's state-owned healthtech agency, aimed at innovating public healthcare services.

As a result, Lunit will provide its chest X-ray AI image analysis solution, "Lunit Insight CXR," to local public hospitals.

According to Lunit, SYNAPSE is a government agency responsible for the integrated management of IT systems in Singapore's public hospitals. To manage medical data in Singapore's public hospitals, it is mandatory to utilize the systems of this agency.

SYNAPSE plans to install the AimSG service in major public hospitals in Singapore. Once installed, Lunit's AI solution will be utilized in all hospitals, according to Lunit.

Lunit expects positive effects on medical innovation through the use of AI, anticipating improved diagnostic accuracy and shortened treatment times for local medical professionals.

"This collaboration with SYNAPSE will be an opportunity to boast our company's global competitiveness, significantly contributing to public healthcare innovation in Singapore," said Suh Beom-Seok, CEO of Lunit.

"Particularly, since Singapore plays a central role in the ASEAN region, our success here is expected to serve as a foundation for expanding throughout the entire ASEAN region," he added.

Write to Hyun-Ah Oh at 5hyun@hankyung.com